EpiBone

Regeneus is a company focused on providing analysis of air freight operations within the logistics and transportation sector. Its main offerings include insights into the handling of urgent air cargo, the decision-making processes involved, and the operational realities of Australia's air freight network under time-critical conditions. The company serves sectors that require shipping solutions, such as medical, humanitarian, and critical component industries. It is based in Paddington, New South Wales.

BioLab Sciences is a company involved in regenerative medicine and advanced wound care within the healthcare sector. They provide products such as membrane wraps and protective coverings. The company serves the medical and healthcare industry. It is based in Scottsdale, Arizona.

DiscGenics is a clinical stage biopharmaceutical company engaged in the development of cell-based therapies within the healthcare industry. The company's offerings include injectable cell therapies aimed at alleviating pain and restoring function for patients with degenerative diseases of the spine, particularly lumbar disc degeneration. DiscGenics serves the healthcare sector, primarily addressing conditions associated with chronic back pain. It was founded in 2007 and is based in Salt Lake City, Utah.

Novadip Biosciences is a clinical-stage biopharmaceutical company involved in developing regenerative tissue products within the bone and tissue regenerative medicine sector. The company provides treatments for conditions such as large bone defects, bone non-union, and spinal fusion. Novadip's products include the allogeneic NVD-X3 and the autologous NVD-003. It was founded in 2013 and is based in Mont-Saint-Guibert, Belgium.

Videregen offers a commercially available organ replacement product to address the chronic shortage of organs for transplantation. Formed in 2011 as a spin-out from Northwick Park Institute of Medical Research in London, it uses its proprietary technology to produce biological scaffolds to which a patient's own stem cells are added, creating a bespoke organ replacement.

Novo Biosciences is a biotechnology company focused on pioneering new therapies in regenerative medicine. The company's main offerings include the development of breakthrough drugs designed to regenerate damaged organs and tissues by activating the body's inherent self-repair mechanisms. Novo Biosciences primarily targets the medical healthcare sector with its innovative pharmacotherapies. It was founded in 2013 and is based in Bar Harbor, Maine.